These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 309898)

  • 1. Differential protective effects of immune lymphoid cells against transplanted line Ib leukemia and immune polioencephalomyelitis.
    Duffey PS; Lukasewycz OA; Olson DS; Murphy WH
    J Immunol; 1978 Dec; 121(6):2316-21. PubMed ID: 309898
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune mechanisms in leukemia: protective capacity of the major lymphoid cell compartments.
    Lukasewycz OA; Duffey PS; Murphy WH
    J Immunol; 1976 Apr; 116(4):976-81. PubMed ID: 1082909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenetic mechanisms in immune polioencephalomyelitis: quantitative evaluation of protective and pathogenic effects of lymphoid cells.
    Duffey PS; Lukasewycz OA; Martinez D; Murphy WH
    J Immunol; 1976 May; 116(5):1332-6. PubMed ID: 1270798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune mechanisms in leukemia: suppression of cellular immunity by drugs and x-irradiation.
    Martinez D; Lukasewycz OA; Murphy WH
    J Immunol; 1975 Sep; 115(3):724-9. PubMed ID: 1151076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro immune response of human peripheral lymphocytes. IV. Specific induction of human suppressor T cells by an antiserum to the T leukemia cell line HSB.
    Hirano T; Kishimoto T; Kuritani T; Muraguchi A; Yamamura Y; Ralph P; Good RA
    J Immunol; 1979 Sep; 123(3):1133-40. PubMed ID: 313946
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution and lysis of weakly and strongly immunogenic malignant lymphoid cells in normal and immune mice: effects of prior exposure to heat or X-irradiation.
    Nawrocki JF; Look AT; Selwa JF; Haggis JR; Murphy WH
    J Natl Cancer Inst; 1984 May; 72(5):1085-94. PubMed ID: 6585585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunoadsorbents: a simplified technique for separation of lymphoid cell populations.
    Kedar E; Ortiz de Landazuri M; Bonavida B
    J Immunol; 1974 Mar; 112(3):1231-43. PubMed ID: 4590702
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulation of lymphoid cells in mice infected with Friend leukemia virus.
    Bainbridge DR; Bendinelli M
    J Natl Cancer Inst; 1972 Sep; 49(3):773-81. PubMed ID: 4539617
    [No Abstract]   [Full Text] [Related]  

  • 10. The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens.
    Motta R
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):161-7. PubMed ID: 4315341
    [No Abstract]   [Full Text] [Related]  

  • 11. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct.
    Matulonis U; Dosiou C; Freeman G; Lamont C; Mauch P; Nadler LM; Griffin JD
    J Immunol; 1996 Feb; 156(3):1126-31. PubMed ID: 8557988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms in leukemia: evaluation of immunocompetent cell populations.
    Lukasewycz OA; Martinez D; Murphy WH
    J Immunol; 1975 May; 114(5):1491-6. PubMed ID: 1091703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular immune capacity of mice with transplanted lymphoid leukaemia.
    Boranic M; Poljak-Blazi M
    Biomedicine; 1976 Jun; 25(4):141-4. PubMed ID: 782579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies of the guinea pig L2C leukemia.
    Green I; Forni G; Konen T; Hu CP; Schwartz BD; Kask A; Shevach EM
    Fed Proc; 1977 Aug; 36(9):2264-7. PubMed ID: 328308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.